BACKGROUND: Community trends of acute decompensated heart failure (ADHF) in diverse populations may differ by race and sex.
U
nderstanding population-based trends in heart failure (HF) incidence and survival is important for planning and evaluating prevention and treatment strategies. The Institute of Medicine emphasized the importance of monitoring the cardiovascular health of the country and the value of timely, highquality, population-based data on the incidence of heart disease and its risk factors.
1,2 HF was estimated to affect 5.7 million US adults in 2012, with 915 000 incident cases. 3 Its prevalence is expected to rise to 8.4 million by 2030. 4 A recent population-based study in Olmsted County, MN, suggested that the incidence of HF declined from 2000 to 2010, with HF with reduced ejection fraction (HFrEF) declining at a faster rate than HF with preserved ejection fraction (HFpEF). 5 Although HF survival has improved compared with >25 years ago, 6 median survival remains at ≈5 years. 5, 7 Higher mortality was seen among those with HFrEF compared with HFpEF and among men compared with women. 8 However, these trends in HF incidence and survival were observed in homogenous populations comprised of >90% whites in a single US community, and included outpatient and chronic stable cases. Separating acute from chronic HF in more diverse US communities would enhance our understanding of HF trends and its burden in the general population. The ARIC study (Atherosclerosis Risk in Communities) was the first to differentiate hospitalization rates of acute decompensated HF (ADHF) from chronic stable HF in a biracial community-based population. 9 We present here the 10-year trends of validated first and recurrent ADHF hospitalizations and case fatality from 4 US communities.
METHODS
The data and study materials are available to other researchers for the purposes of reproducing the results, subject to completion of a data use agreement. 10 
Study Population
Beginning in 2005, the ARIC study conducted continuous and comprehensive surveillance of hospitalized HF events for residents ≥55 years of age in 4 US communities: Forsyth County, NC; Jackson, MS; Minneapolis, MN, suburbs; and Washington County, MD. Because of small numbers, blacks in Minneapolis and Washington County and persons reported to be neither black nor white were excluded from these analyses. The population of eligible blacks and whites ≥55 years of age in the 4 communities was 225 395 persons in 2014 (56% women, 21% black).
Hospital Surveillance, Case Ascertainment, and Event Classification
Methods of event ascertainment and classification have been described previously. 11 Briefly, a stratified random sample of eligible hospitalizations for HF in 2005 to 2014 was selected based on 3 criteria: (1) 4 , 786.0x) in any position; (2) ≥55 years of age at the time of hospital discharge; and (3) home address within boundaries of the ARIC communities. The sampling varied by ICD-9, Clinical Modification discharge codes (428 and non-428), field center, sex, and race (by race in Forsyth County and Jackson only) to achieve similar standard errors across these groups. 12 It is important to note that, unlike the cohort component of the ARIC study, the ARIC study community surveillance samples hospitalizations across the 22 hospitals in the ARIC communities and cannot follow a specific patient to link the current with a past hospitalization, including past hospitalizations outside of these ARIC study hospitals.
Medical records of eligible hospitalizations (unweighted n=23 410) were abstracted by trained abstractors if there was any evidence of decompensation or new onset of HF symptoms or any mention by a physician that HF was the reason for hospitalization. Abstracted cases (unweighted
Clinical Perspective
What Is New?
• Ten-year rates and trends of hospitalized acute decompensated heart failure (ADHF) differ by race/ sex and heart failure (HF) type (preserved ejection fraction versus reduced ejection fraction) in the ARIC study (Atherosclerosis Risk in Communities).
• Acute HF with reduced ejection fraction was more common in black men and white men, whereas acute HF with preserved ejection fraction was most common in white women.
• Rates of hospitalized ADHF increased over time, with higher rates in blacks and rising cases of HF with preserved ejection fraction.
• Mortality rates were ≈30% at 1 year, with a more pronounced decrease over time in blacks, but generally did not differ by HF type.
What Are the Clinical Implications?
• Although overall national trends may vary by geographic region, blacks in the 4 ARIC communities had higher rates and trends of ADHF hospitalizations compared with whites, but they also had lower age-adjusted 1-year case fatality in each sex group (particularly black women with HF with preserved ejection fraction). • This racial difference may be related to younger age of HF onset, comorbidities, and other communitylevel and socioeconomic factors that may affect HF trends.
• Given the national focus to decrease readmission rates for ADHF, more attention on the medical management of hospitalized patients with ADHF is also warranted. The focus of the ARIC study has been to identify HF events that become serious enough to require hospitalization, and among these we look for "first hospitalizations" as a proxy for incident cases, 9 as we have done for other cardiovascular diseases. 13 Vital status within 1 year after admission was determined by linkage with the National Death Index. Institutional review boards approved the study protocol at all participating hospitals in the ARIC communities (no informed consent was required).
Statistical Analysis
After excluding non-ADHF hospitalizations (unweighted n=6202), a small number of nonblack minorities (n=225) and blacks in 2 predominately white communities (Minneapolis and Washington County; n=168), the final sample included 8746 (weighted n=40 173) validated ADHF hospitalizations from 2005 to 2014 (Figure 1 ). To account for the sampling design, all analyses were conducted using survey procedures and weighted by the inverse of the sampling probabilities. Differences by race and sex in the probability of a hospitalization being first or in probability of HFrEF/HFpEF were tested using Wald tests based on logistic regression models. Sex-and racespecific annual event rates per 1000 persons were computed based on population inter-and postcensal estimate denominators and adjusted for age by the direct method, using the 2000 US population estimates as the standard. Annual 28-day and 365-day (1-year) case fatality percentages were computed based on denominators of those who were hospitalized with ADHF in the ARIC population and adjusted for age by the direct method using the ARIC combined hospitalized ADHF events as the standard. Case fatality analysis was available for all HF events hospitalized from 2005 to 2014 through National Death Index linkage data. Age-adjusted trends are reported as average annual percentage change (AAPC) by race and sex, using Poisson regression for first and recurrent hospitalization rates and using logistic regression for case fatality. Null hypotheses of no difference in the trends by race and sex were tested using Wald tests of the coefficients of interactions between main effects in these models.
All data analysis was performed using SAS version 9.1.3 (SAS Institute) or SUDAAN release 9.0. (29) 1087 (40) 1076 (10) 1423 (15) 839 (30) 1225 (46) 397 (9) 602 (13) 65-74 9595 (24) 1021 (28) 832 (30) 1932 (19) 2297 (25) 811 (29) 739 (28) 880 (21) 1082 (24) 75+ 22 891 (57) 1556 (43) 826 (30) 7386 (71) 5555 (60) 1155 (41) 691 (26) 2944 (70) 2778 (62) HF type HFpEF 15 535 (39) 1542 (43) 791 (29) 5646 (54) 3251 (35) 1018 (36) 462 (17) 1899 (45) 926 (21) HFrEF 20 015 (50) 1531 (42) 1683 (61) 3431 (33) 4941 (53) 1425 (51) 1971 (74) 1841 (44) 3192 (72) Recovered HFrEF 1154 (3) 63 (2) 71 (3) 247 (2) 286 (3) 89 (3) 76 (3) 183 (4) 139 (3) Unknown subtype of HF* 3468 (9) 478 (13) 200 (7) 1070 (10) 797 (9) 274 (10) 146 (5) 298 (7) 205 (5 Chronic kidney disease 2711 (7) 357 (10) 371 (14) 364 (4) 457 (5) 315 (11) 225 (8) 203 (5) 419 (9) Atrial fibrillation or flutter 16 129 (40) 755 (21) 566 (21) 4297 (41) 4102 (44) 812 (29) 709 (27) 2448 (58) Values are presented as n (%) except for mean age, where values are mean (SD). Percentages were rounded to the nearest integer. ADHF indicates acute decompensated heart failure; ARIC, Atherosclerosis Risk in Communities; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; and HFrEF, heart failure with reduced ejection fraction.
*Missing data for ejection fraction.
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men, 53% in white men, 42% in black women, and 33% in white women. Although there was no interaction between race and sex (P=0.24), first hospitalized events were more likely to be HFrEF in men (P<0.0001) and in blacks (P<0.0001). Recurrent hospitalized ADHF events were more commonly for HFrEF for all race-sex groups. Similarly, there was no interaction between race and sex (P=0.40), and recurrent events were more likely to be HFrEF in men (P<0.0001) and in blacks (P=0. 0007).
For those with first hospitalized ADHF, black patients compared with whites were younger, had fewer cardiac comorbidities (including prevalent coronary heart disease, myocardial infarction history, and atrial arrhythmias), but had more hypertension, diabetes mellitus, and chronic kidney disease. Signs and symptoms of ADHF presentation were similar across all race-sex groups, with dyspnea and edema as the most common. Similar patterns of demographic and clinical characteristics were observed for those with recurrent ADHF hospitalizations. Table 2 shows the age-adjusted average annual event rates of ADHF hospitalizations and AAPC by race-sex group, HF type, and HF history (first versus recurrent). The highest event rates were in black men, followed by black women, white men, and white women. ADHF rates increased over the 10 years (AAPC: black women +4.3%, black men +3.7%, white women +1.9%, white men +2.6%), mostly reflecting more acute HFpEF. When stratified by HF type and HF history, the average annual rate of first hospitalized HFpEF was higher in blacks than in whites, and the average annual rate of first hospitalized HFrEF was higher in blacks than in whites.
Temporal Trends in ADHF Hospitalizations
Rates of first hospitalized ADHF increased each year for each race-sex group. The AAPC in the rates of all first ADHF hospitalizations was similar among all race-sex groups shown, ranging from an average 6.3% increase per year in black women to 1.8% in white women. Figure 2 depicts the age-adjusted first hospitalization rates per year by HF type and race-sex group. The increase in the rate of first hospitalized ADHF mostly reflected the increase in rates of HFpEF in each race-sex group over the 10-year time period. The age-adjusted average annual increases in first hospitalized HFpEF were at higher magnitude compared with the AAPC of all first hospitalized ADHF, with black women having the highest rise (an average 10.0% per year).
Changes in HFrEF rates were modest but showed different race-sex patterns. White men were the only race-sex group to have a rising rate of first hospitalized HFrEF. Changes in rates of first HFrEF were not statistically significant for blacks and white women. (Table 2) . However, the age-adjusted average annual increase in recurrent events was only statistically significant for women with HFpEF and black men with HFrEF. Tables 3 and 4 display the age-adjusted average annual 28-day and 1-year case fatality proportions by race-sex group, HF type, and HF history, respectively. For all ADHF hospitalizations, and Table 4 , only blacks showed decreased 1-year mortality over time (AAPC: black women -5.4%, black men -4.6%), with rates differing by HF type (AAPC: black women HFpEF -7.1%, black men HFrEF -4.7%). For those with a first-time hospitalization for ADHF, the age-adjusted average annual 28-day and 1-year case fatality proportions were higher among whites compared with blacks aggregated across HF type (P=0.02 and P=0.003, respectively) ( Tables 3 and 4) . Figure 3 demonstrates the age-adjusted 1-year case fatality per year by HF type and race-sex group. In general, case fatality after a first ADHF hospitalization showed modest changes from 2005 through 2014, although 1-year case fatality significantly decreased by an average of 4.7% per year in black women. Among those with HFpEF, whites had higher 28-day and 1-year case fatality compared with blacks (P=0.01 and P=0.009, respectively). Changes in age-adjusted 28-day case fatality were not statistically significant for any race-sex group (Table 3 and Figure I in the online-only Data Supplement).
Case Fatality
For patients with recurrent hospitalized ADHF, the average annual case fatality appeared higher in men than in women (Tables 3 and 4 ), but these sex-based differences were generally not statistically different. One-year mortality rates decreased by ≈6% per year for both black women and black men over the 10 years, particularly black men with HFrEF.
Sensitivity Analysis
The trends in HF incidence were sensitive to the definition of first hospitalization for ADHF. Sensitivity analyses were performed with first ADHF redefined more broadly as those with no history of HF diagnosis (re- 
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gardless of presence of a hospitalization); this shifted the majority of hospitalized cases to recurrent ADHF. Demographic and clinical characteristics were similar to the population classified as an event with no previous hospitalization for HF (Table II in the online-only Data Supplement). As expected, event rates were similarly shifted, with significant trends seen primarily in the recurrent ADHF cases (Table 5 and Figure 4) , and case fatality rates changed modestly for both first and recurrent ADHF cases, with a ≤5% absolute decrease in estimates (Tables 6 and 7) . Trends in 1-year case fatality were similar (decreases over time for black women with first ADHF, and both black women and black men with recurrent ADHF). However, 1-year case fatality increased over time for white women with first HFrEF (Table 7) . These different trends in event rates and case fatality likely reflect differences in the case mix of ADHF created by changing the definition of a first event.
To enhance comparability with other community population studies (eg, Olmsted County 5, 8 ), we defined HFrEF as EF <50% since the beginning of ARIC HF Community Surveillance in 2005. Using other cut points, such as EF ≤40 or ≤45%, resulted in higher event rates for HFpEF and lower event rates for HFrEF as expected but did not substantially alter the trends observed using the original EF cut point (Table III in 
DISCUSSION
From 2005 to 2014, in the biracial ARIC study communities, the average age-adjusted rates of first hospitalized HF were higher in blacks, with differences seen by HF type and sex. Over these 10 years, the rates of all first hospitalizations for ADHF increased in all racesex subgroups, most notably for HFpEF. Although the rate of first hospitalization for acute HFrEF was higher in black men, a significant but modest rise in first hospitalized acute HFrEF rate was seen in only white men; women and black men showed no statistically significant changes in HFrEF trends.
Reasons for the observed differences over time by sex, race, and HF type may be related to temporal trends in coding hospital discharges and using biomarkers such as B-type natriuretic peptide for diagnosing HF. Whether increased recognition of HFpEF AAPC indicates average annual percentage change; ADHF, acute decompensated heart failure; ARIC, Atherosclerosis Risk in Communities; CF, case fatality; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; and HFrEF, heart failure with reduced ejection fraction. N denotes the number of deaths. *P<0.05 for comparison between race-sex subgroups within the HF category. †P<0.05 for comparison between race subgroups within the HF category.
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contributes to an increase in HFpEF diagnosis and thus its incidence is unknown. However, differences by race and sex may be related to different trends in comorbidities or etiologies of HF. For example, the incidence of acute myocardial infarction and rates of coronary heart disease deaths are decreasing. 14, 15 Perhaps this trend may explain why there is no significant change in HFrEF incidence over time because coronary heart disease is associated more with HFrEF than HFpEF. Common comorbidities related to HFpEF are on the rise and include atrial fibrillation, 16 hypertension, obesity, and diabetes mellitus. 17 There are well-recognized race and sex differences for these known risk factors for HF and other cardiovascular diseases (eg, blacks have a higher prevalence of hypertension than whites, and black women have a higher prevalence of obesity compared with white women). 3 Black patients in the ARIC communities were more likely to have chronic kidney disease, but whether chronic kidney contributes to more ADHF is controversial. 18 Further investigation is needed to determine whether a specific comorbidity compared with another is more associated with first hospitalization for ADHF. 8 and recent preliminary findings in the Framingham cohort for which HFpEF incidence increased over 19 years. 22 The recurrent HF hospitalization trends in the ARIC study are also in contrast to the 10-year trends seen in the Medicare population and the National Inpatient Sample, which included both incident and recurrent hospitalizations and showed a decline in all HF hospitalization from 1998 to 2008 and 2002 to 2013, respectively, with blacks having higher HF hospitalization rates than whites. 23, 24 The heterogeneity of findings across studies likely reflects differences in population demographics and definitions of HF. It is notable that our ARIC community surveillance study population was restricted to white and black residents AAPC indicates average annual percentage change; ADHF, acute decompensated heart failure; ARIC, Atherosclerosis Risk in Communities; CF, case fatality; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; and HFrEF, heart failure with reduced ejection fraction. N denotes the number of deaths. *P<0.05 for comparison between race subgroups within the HF category. †P<0.05 for comparison between sex subgroups within the HF category.
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≥55 years of age, and our definition of HF incidence is based on first decompensation leading to hospitalization and did not include outpatient cases. The Olmsted County population sample and Framingham cohort are relatively homogenous, with >90% of participants of white race/ethnicity, include both outpatient and inpatient HF cases (identified by ICD-9 codes and validated using the Framingham Study HF criteria), and did not AAPC indicates average annual percentage change; ADHF, acute decompensated heart failure; AER, average event rates (number of ADHF events per year) per 1000 persons; ARIC, Atherosclerosis Risk in Communities; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; and HFrEF, heart failure with reduced ejection fraction.
*First ADHF was defined as cases with no history of prior HF diagnosis. †P<0.05 for comparison between race subgroups within the HF category. ‡P<0.05 for comparison between sex subgroups within the HF category. Circulation. 25 Thus, more HFpEF and less HFrEF were classified in their analyses. The UK CPRD cohort was also >95% white. 19 The Medicare population is restricted to ≥65 years of age, whereas >20% of the black population in the ARIC communities were 55 to 64 years of age. HF cases in the National Inpatient Sample, the Medicare populations, and the UK CPRD sample were classified using administrative claims data based on inpatient or outpatient ICD-9, Clinical Modification or ICD-10 codes, defining incident HF as the initial HF hospitalization within the specified time period, and did not involve case adjudication. It is important to note that our previous reports suggest that HF hospitalization identified solely by ICD-9 codes may not accurately estimate the rates of ADHF, 9 missing ≤50% of cases. 26 Despite the rise in the rate of first hospitalization for ADHF, especially for HFpEF, there were no consistent or significant changes in 28-day mortality after hospital discharge from 2005 to 2014, regardless of LVEF or HF type, or history of hospitalized HF. However, 1-year mortality decreased over the 10 years, by 5% to 7% per year, in black women with first hospitalized ADHF and recurrent hospitalized ADHF, and in black men with recurrent ADHF. Yet 1-year survival was similar for HFpEF and HFrEF for most race-sex groups regardless of history of hospitalized HF (except for black men with recurrent HFrEF, whose 1-year mortality decreased 5.8% per year). This minimal change in survival by HF type is in contrast to reports from Olmsted County, where the survival is better for HFpEF than HFrEF 5, 8 and the trends where HF type was not specified. 15, 27 Our unique results may be related to the more diverse, biracial population of the ARIC population. Lower age-adjusted case fatality rates were observed in blacks in each sex group (particularly among blacks with HFpEF), despite higher first hospitalization rates of ADHF rates compared with whites. A similar racial difference was seen in the HFpEF cohort of the Get With the Guidelines-Heart Failure registry (linked to the Centers for Medicare & Medicaid Services administrative data) between 2006 and 2014. 28 This racial difference 
may be related to younger age of HF onset in blacks and incomplete adjustment for other related factors. Moreover, it is notable that the average age-adjusted 1-year mortality rates for first hospitalized ADHF, regardless of HF type, is ≈30% for all race-sex groups, which is higher than estimates of ≈20% based on populations from the Framingham Heart Study 3 and Olmsted County 5 (which included outpatient, presumably milder cases) but similar to estimates based on all acute HF hospitalizations from the Worchester Heart Failure Study 27 and the Medicare population. 15 Particular to the ARIC study is the ability to differentiate recurrent ADHF hospitalizations, which were associated with modestly higher 1-year mortality rates compared with first hospitalized cases, with no significant change over time and no demonstrable differences by race-sex groups. Reasons for these higher 1-year mortality estimates for both first and recurrent hospitalized ADHF events in the ARIC communities are most likely related to the definition of our hospitalized HF cases because only hospitalized cases that were considered acute and decompensated were included, which would reflect a sicker patient population. Moreover, compared with the Olmsted County sample, 5 this ARIC population was older and included more patients with comorbidities such as coronary heart disease, hypertension, diabetes mellitus, and obesity. Evidencebased HF therapy may also be underprescribed in the ARIC communities (eg, only 50% of patients with HFrEF were on optimal medical therapy). 29 Given the focus of providers, payors, and healthcare systems to decrease readmission rates for ADHF, seeing these survival trends in both first and recurrent hospitalized ADHF may translate to more attention on the medical management of hospitalized patients with HF.
Our study is not without limitations. A design limitation of community-wide, retrospective surveillance of hospitalizations that use survey sampling methods is that follow-up of individual patients beyond vital status is not routinely incorporated. Therefore, details about the patient's care beyond that sampled hospitalization are limited to only what is noted in the index hospital records, which may result in potential misclassification between first and recurrent ADHF hospitalizations. Because subsequent and prior hospitalizations cannot be linked to the index ADHF hospitalization, recurrent ADHF could have been misclassified in our study as a first hospitalization for ADHF. Furthermore, our definition of incident hospitalized HF is based on the lack of prior hospitalization for HF and includes patients with a prior diagnosis of HF (56%). Therefore, cases we classified as first hospitalized events may in fact include patients who experienced HF symptoms and received treatment outside the hospitalization setting. First hospitalization rates are also subject to misclassification bias with potential overestimation if prior HF hospitalizations were not noted in the abstracted medical records, especially in the early years before widespread use of electronic medical records. Therefore, these limitations could have led us to overestimate the rate of first hospitalization for ADHF. In a sensitivity analysis with an alternative definition of first ADHF, the pattern of increased event rates shifted from first to recurrent hospitalization for ADHF. 
However, there is variation in the literature as to the optimal method for pinpointing the first onset of HF in population based studies. Since its inception, ARIC Community Surveillance has focused on identifying cardiovascular events that are serious enough to require hospitalization, as we have done for coronary heart disease since 1987. 11 First hospitalization is a reasonable surrogate for HF incidence based on estimates from other studies. For example, most incident HF cases diagnosed in the outpatient setting in Olmsted County (74%) were hospitalized within 1.7±3.1 years of the diagnosis. 7 As with any observation study, this analysis was not powered to detect interactions between various subgroups (eg, race-sex interaction by HF type). However, we present the results stratified by race, sex, and HF type, which would address potential significant subgroup interactions. The present study did not include outpatient HF events that did not eventually result in hospital admission. The goal and design of ARIC HF Community Surveillance was to assess the burden of hospitalized ADHF rather than the total burden of HF, which naturally restricts case identification. Nevertheless, the ARIC study has been the first to differentiate hospitalization rates of ADHF from chronic HF in a biracial community-based population, focusing on acute HF to provide better estimates of trends of the HF burden in the general population.
Other limitations of this study include that our study population originates from 4 US communities, is restricted to those ≥55 years of age, and therefore does not represent the total US population. National trends will vary given the different proportions of different racial and ethnic groups across the country.
In summary, in this biracial population of 4 US communities, trends in hospitalized ADHF from 2005 to 2014 differ by sex and race, with an overall increase in first hospitalization events primarily because of HFpEF. Mortality rates from ADHF are higher than what has been previously reported in other US population samples. The trends seen in the present study should be confirmed in other diverse population-based studies. 
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